About Matthew Cohen
Form D filings for IMMvention Therapeutix from 2020 to 2023 list Matthew Cohen as director.
Matthew Cohen first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Cohen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Cohen works with at each company, as listed on that company's latest Form D.
IMMvention Therapeutix, Inc. · Form D, Jan 10, 2023
JT
Jenny Ting
Director
MT
Marilyn Thompson
Executive officer
MV
Mark Velleca
Director
AG
Anil Goyal
Chief Executive Officer and director
LO
Lev Osherovich
Director
BS
Benjamin Scruggs
Director